Treatment of SARS-CoV-2: How far have we reached?
Clicks: 251
ID: 105737
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
250 views
11 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field.
| Reference Key |
ahsan2020treatmentdrug
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ahsan, Waquar;Javed, Shamama;Bratty, Mohammed Al;Alhazmi, Hassan A;Najmi, Asim; |
| Journal | drug discoveries & therapeutics |
| Year | 2020 |
| DOI |
10.5582/ddt.2020.03008
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.